デフォルト表紙
市場調査レポート
商品コード
1511798

DNA合成の市場規模、シェア、動向分析レポート:サービスタイプ別、長さ別、用途別、最終用途別、地域別、セグメント別予測、2024年~2030年

DNA Synthesis Market Size, Share & Trends Analysis Report By Service Type (Gene Synthesis, Oligonucleotide Synthesis), By Length, By Application (Research Development, Diagnostics), By End-use, By Region, And Segment Forecasts, 2024 - 2030


出版日
ページ情報
英文 120 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
DNA合成の市場規模、シェア、動向分析レポート:サービスタイプ別、長さ別、用途別、最終用途別、地域別、セグメント別予測、2024年~2030年
出版日: 2024年06月04日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

DNA合成市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界のDNA合成市場規模は2030年までに82億6,000万米ドルに達する見込みです。

この市場は、患者の治療を決定するのに役立つ個別化ゲノム配列決定への注目の高まりにより、2024年から2030年にかけて15.30%のCAGRを記録すると予測されています。さらに、DNA合成は、疾患モニタリング、創薬、薬理ゲノミクスへの広範な応用のための生物学的研究活動に革命をもたらす能力を有しています。

COVID-19のパンデミックは、COVID-19感染症やさまざまなタイプのがんの治療のためのmRNAベースのワクチンの採用にプラスの影響を与えました。mRNAの有用性は合成DNAの需要を押し上げます。さらに、COVID-19研究の主な焦点はDNA合成です。合成DNAはすべてのPCR分析で使用されます。患者はサンプル中に存在するかもしれないゲノムDNAを同定するためにDNAプライマーを使う必要があります。

酵素工学の進歩は、酵素的DNA合成のためのさまざまなアプローチの開発を後押ししています。酵素を使用して核酸を必要な配列で連鎖させるもので、広く応用するにはさらなる最適化が必要です。多くの市場関係者が、ヌクレオチドの効率的な酵素生産を最短時間で行うための新技術の開発に取り組んでいます。例えば、2021年5月、Ribbon Biolabsは10,000塩基対のDNA配列を合成するという使命を設定し、2021年12月までに20,000塩基対のDNA分子というマイルストーンを達成しました。

遺伝子合成は、特定のヌクレオチド配列による標的変異誘発や、所望の表現型発現の制御など、幅広い用途があります。遺伝子合成は遺伝子工学の主要な基礎を形成し、高い特異性を持つ抗体断片の開発によって抗体の範囲と質を著しく向上させました。

オリゴヌクレオチド合成は、核酸の比較的短い断片を、必要とされる決定的な配列で実験室ベースで生産することです。この技術は、所望の配列のカスタムメイドのオリゴヌクレオチドを迅速かつ安価に入手することを容易にする、極めて堅牢な手法です。各社は、ヌクレオチド合成プロセスを支援するためにオリゴヌクレオチド・ライブラリーを考案してきました。例えば、2022年7月、Ribbon Biolabs社は、多様なオリゴヌクレオチドライブラリーを用いたヌクレオチド分子の合成に関するRibbon Biolabs社の方法に関する米国特許を取得したと発表しました。この方法は、オリゴヌクレオチドの予め構築されたライブラリーから構成され、効率的なアクセスが可能です。

DNA合成市場レポートのハイライト

  • 2023年にはオリゴヌクレオチド合成セグメントが業界を支配しました。このセグメントのシェアが大きいのは、ゲノミクス研究、個別化医療、疾患の遺伝的基盤の理解に焦点が当てられているためです。
  • オリゴヌクレオチド合成セグメントは、2023年により大きな収益シェアで市場を独占しました。遺伝子疾患に対する認識と理解の高まりが、診断と潜在的な治療介入におけるオリゴヌクレオチドの需要に寄与しています。
  • 研究開発セグメントは、2023年に63.30%のシェアで市場を独占しました。これは、世界中で進行中の調査研究をサポートするためにDNA合成の使用が増加しているためです。
  • 北米が市場を独占し、2023年の収益シェアは39.76%でした。同地域は、一般市民の意識の高まり、医療施設の充実、研究開発への多額の投資によって市場が成長しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 DNA合成市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助的な市場見通し。
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • DNA合成市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19の影響分析

第4章 DNA合成市場:サービスタイプの推定・動向分析

  • セグメントダッシュボード
  • 世界のDNA合成市場のサービスタイプの変動分析
  • 世界のDNA合成市場規模と動向分析、サービスタイプ別、2018年から2030年
  • オリゴヌクレオチド合成
  • 遺伝子合成

第5章 DNA合成市場:長さの推定・動向分析

  • セグメントダッシュボード
  • 世界のDNA合成市場の長さの変動分析
  • 世界のDNA合成市場の規模と動向分析、長さ別、2018年~2030年
  • オリゴヌクレオチド合成
  • 遺伝子合成

第6章 DNA合成市場:用途の推定・動向分析

  • セグメントダッシュボード
  • 世界のDNA合成市場の用途の変動分析
  • 世界のDNA合成市場規模と動向分析、用途別、2018年~2030年
  • 研究開発
  • 診断
  • 治療薬

第7章 DNA合成市場:最終用途の推定・動向分析

  • セグメントダッシュボード
  • 世界のDNA合成市場の最終用途変動分析
  • 世界のDNA合成市場規模と動向分析、最終用途別、2018年~2030年
  • バイオ医薬品・診断薬企業
  • 学術調査機関
  • 契約調査機関

第8章 DNA合成市場:地域推定・動向分析

  • 地域別市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 市場規模、予測動向分析、2018年~2030年
  • 北米
    • 北米市場推計・予測、2018年~2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州市場推計・予測、2018年~2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋地域
    • アジア太平洋市場推計・予測、2018年~2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ラテンアメリカ市場推計・予測、2018年~2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカ市場推計・予測、2018年~2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第9章 競合情勢

  • 企業/競合の分類
  • 戦略マッピング
  • 企業市況分析、2023年
  • 企業プロファイル/上場企業
    • Thermo Fisher Scientific Inc.
    • Twist Bioscience
    • BIONEER CORPORATION
    • Eton Bioscience, Inc
    • LGC Biosearch Technologies
    • IBA Lifesciences GmbH
    • Eurofins Scientific
    • Integrated DNA Technologies, Inc.
    • Quintara Biosciences
    • GenScript
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global DNA synthesis market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 4 Global DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 5 Global DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 North America DNA synthesis market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 9 North America DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 10 North America DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 U.S. DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 13 U.S. DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 14 U.S. DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Canada DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 17 Canada DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 18 Canada DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Europe DNA synthesis market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 22 Europe DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 23 Europe DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 24 Europe DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Germany DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 26 Germany DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 27 Germany DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 28 Germany DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 UK DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 30 UK DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 31 UK DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 32 UK DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 France DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 34 France DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 35 France DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 36 France DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Italy DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 38 Italy DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 39 Italy DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 40 Italy DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Spain DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 42 Spain DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 43 Spain DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 44 Spain DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Denmark DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 46 Denmark DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 47 Denmark DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 48 Denmark DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Sweden DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 50 Sweden DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 51 Sweden DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 52 Sweden DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Norway DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 54 Norway DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 55 Norway DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 56 Norway DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific DNA synthesis market, by country, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 China DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 63 China DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 64 China DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 65 China DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Japan DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 67 Japan DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 68 Japan DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 69 Japan DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 India DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 71 India DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 72 India DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 73 India DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 South Korea DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 75 South Korea DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 76 South Korea DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 77 South Korea DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Australia DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 79 Australia DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 80 Australia DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 81 Australia DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Thailand DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 83 Thailand DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 84 Thailand DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 85 Thailand DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Latin America DNA synthesis market, by country, 2018 - 2030 (USD Million)
  • Table 87 Latin America DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 88 Latin America DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 89 Latin America DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 90 Latin America DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 91 Brazil DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 92 Brazil DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 93 Brazil DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 94 Brazil DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Mexico DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 96 Mexico DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 97 Mexico DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 98 Mexico DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 99 Argentina DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 100 Argentina DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 101 Argentina DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 103 MEA DNA synthesis market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 105 MEA DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 106 MEA DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 107 MEA DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 108 South Africa DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 109 South Africa DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 110 South Africa DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 116 UAE DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 117 UAE DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 118 UAE DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE DNA synthesis market, by end-use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait DNA synthesis market, by service type, 2018 - 2030 (USD Million)
  • Table 121 Kuwait DNA synthesis market, by length, 2018 - 2030 (USD Million)
  • Table 122 Kuwait DNA synthesis market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait DNA synthesis market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 DNA synthesis market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Synthetic biology market value, 2023 (USD Billion)
  • Fig. 17 Market trends & outlook
  • Fig. 18 PESTEL analysis
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 DNA synthesis market: Service type outlook & key takeaways
  • Fig. 21 DNA synthesis market: Service type movement analysis
  • Fig. 22 Oligonucleotide synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Standard oligonucleotide synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Custom oligonucleotide synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Gene synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Custom gene synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Gene library synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 DNA synthesis market: Length outlook & key takeaways
  • Fig. 29 DNA synthesis market: Length movement analysis
  • Fig. 30 Oligonucleotide synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Less than 50 nt market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 51-100 nt market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 101-150 nt market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 More than 150 nt market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Gene synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Less than 500 nt market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 501-1,000 nt market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 501-1,000 nt market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 1,501-2,000 nt market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 2,001-2,500 nt market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 More than 2,500 nt market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 DNA synthesis Market: Application outlook & key takeaways
  • Fig. 43 DNA synthesis Market: Application movement analysis
  • Fig. 44 Research and development market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Oligonucleotide synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 NGS market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 CRISPR market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Cloning and mutagenesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Gene synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Synthetic biology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Vaccine development market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Genetic engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 RNAi therapies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Antisense oligonucleotide-based therapies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 DNA synthesis market: End-use outlook & key takeaways
  • Fig. 62 DNA synthesis market: End-use movement analysis
  • Fig. 63 Biopharmaceutical and diagnostics companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Contract research organizations market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Regional marketplace outlook, 2023 & 2030 (USD Million)
  • Fig. 67 Regional marketplace: Key takeaways
  • Fig. 68 North America DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 U.S. DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Canada DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Europe DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 UK DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Germany DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 France DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Spain DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Italy DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Denmark DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Sweden DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Norway DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Asia Pacific DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Japan DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 China DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 India DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 Australia DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Thailand DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key country dynamics
  • Fig. 102 South Korea DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Latin America DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 104 Key country dynamics
  • Fig. 105 Brazil DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 106 Key country dynamics
  • Fig. 107 Mexico DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 108 Key country dynamics
  • Fig. 109 Argentina DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 110 MEA DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 111 Key country dynamics
  • Fig. 112 South Africa DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 113 Key country dynamics
  • Fig. 114 Saudi Arabia DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 115 Key country dynamics
  • Fig. 116 UAE DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 117 Key country dynamics
  • Fig. 118 Kuwait DNA synthesis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 119 Market participant categorization
  • Fig. 120 Global DNA synthesis market position analysis, 2023
  • Fig. 121 Strategic framework
目次
Product Code: GVR-4-68040-009-7

DNA Synthesis Market Growth & Trends:

The global DNA synthesis market size is expected to reach USD 8.26 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 15.30% from 2024 to 2030 owing to the rising focus on personalized genome sequencing that aids determine patient care. In addition, DNA synthesis has the capability to revolutionize biological research activities for widespread applications in disease monitoring, drug discovery, and pharmacogenomics.

The COVID-19 pandemic positively impacted the adoption of mRNA-based vaccines for the treatment of COVID-19 infection and different types of cancers. The utility of mRNA boosts the demand for synthetic DNA. Furthermore, a major focus of Covid-19 research is DNA synthesis. Synthetic DNA is used in all PCR analyses. Patients need to use a DNA primer to identify any genomic DNA that may be present in the sample.

Progress in enzyme engineering is boosting the development of different approaches for enzymatic DNA synthesis. It involves the use of enzymes to chain the nucleic acids together in the required sequence and requires further optimization for its widespread applications. Many market players are striving to devise novel technologies for efficient enzymatic production of nucleotides in the lowest turnaround time. For instance, in May 2021, Ribbon Biolabs set a mission of synthesizing DNA sequences of 10,000 base pairs and accomplished a milestone of a 20,000 base pair DNA molecule by December 2021.

Gene synthesis has a broad spectrum of applications in targeted mutagenesis with a specific sequence of nucleotides along with the regulation of a desired phenotypic expression. It forms the primary basis of genetic engineering, which has significantly leveraged the scope and quality of antibodies by the development of antibody fragments with high specificity.

Oligonucleotide synthesis is the laboratory-based production of relatively short fragments of nucleic acids in a required definitive sequence. The technique is an extremely robust practice that facilitates rapid and inexpensive access to the custom-made oligonucleotides of the desired sequence. Companies have devised their oligonucleotide libraries to aid their nucleotide synthesis processes. For instance, in July 2022, Ribbon Biolabs declared that it secured a U.S. Patent that comprises Ribbon Biolabs' method for the synthesis of a nucleotide molecule using a diverse library of oligonucleotides. The approach comprises a pre-built library of oligonucleotides for efficient access.

DNA Synthesis Market Report Highlights:

  • The oligonucleotide synthesis segment dominated the industry in 2023. The larger share of this segment can be attributed to the focus on genomics research, personalized medicine, and understanding the genetic basis of diseases.
  • The oligonucleotide synthesis segment dominated the market with the larger revenue share in 2023. The growing awareness and understanding of genetic disorders contribute to the demand for oligonucleotides in diagnostics & potential therapeutic interventions.
  • The research and development segment dominated the market with a share of 63.30% in 2023. This is due to the growing use of DNA synthesis to support ongoing research studies across the globe.
  • North America dominated the market and accounted for a 39.76% revenue share in 2023. The region experiences market growth due to heightened public awareness, robust medical facilities, and substantial R&D investments.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service Type
    • 1.2.2. Length
    • 1.2.3. Application
    • 1.2.4. End-use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. DNA Synthesis Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing application of DNA synthesis in clinical diagnostics
      • 3.2.1.2. Changing regulatory environments for genetic research and its applications in healthcare
      • 3.2.1.3. Increasing public-private spending on genomics
      • 3.2.1.4. Technological advancements in gene editing technologies
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost associated with genomics research
      • 3.2.2.2. Lack of skilled professionals and research support in undeveloped countries
  • 3.3. DNA synthesis Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. DNA Synthesis Market: Service Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global DNA Synthesis Market Service Type Movement Analysis
  • 4.3. Global DNA Synthesis Market Size & Trend Analysis, by Service Type, 2018 to 2030 (USD Million)
  • 4.4. Oligonucleotide synthesis
    • 4.4.1. Oligonucleotides synthesis market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Standard oligonucleotides synthesis
      • 4.4.2.1. Standard oligonucleotides synthesis market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Custom oligonucleotide synthesis
      • 4.4.3.1. Custom oligonucleotides synthesis market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Gene synthesis
    • 4.5.1. Gene synthesis market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Custom gene synthesis
      • 4.5.2.1. Custom gene synthesis market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Gene library synthesis
      • 4.5.3.1. Gene library synthesis market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. DNA Synthesis Market: Length Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global DNA Synthesis Market Length Movement Analysis
  • 5.3. Global DNA Synthesis Market Size & Trend Analysis, by Length, 2018 to 2030 (USD Million)
  • 5.4. Oligonucleotide synthesis
    • 5.4.1. Oligonucleotides synthesis market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Less than 50nt
      • 5.4.2.1. Less than 50nt market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. 51-100nt
      • 5.4.3.1. 51-100nt market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. 101-150nt
      • 5.4.4.1. 101-150nt synthesis market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. More than 150nt
      • 5.4.5.1. More than 150nt synthesis market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Gene synthesis
    • 5.5.1. Gene synthesis market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Less than 500nt
      • 5.5.2.1. Less than 500nt market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. 501-1000nt
      • 5.5.3.1. 501-1000nt market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. 1001-1500nt
      • 5.5.4.1. 1001-1500nt synthesis market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.5. 1501-2000nt
      • 5.5.5.1. 1501-2000nt synthesis market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.6. 2001-2500nt
      • 5.5.6.1. 2001-2500nt synthesis market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.7. More than 2500nt
      • 5.5.7.1. More than 2500nt synthesis market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. DNA Synthesis Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global DNA Synthesis Market Application Movement Analysis
  • 6.3. Global DNA Synthesis Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Research & Development
    • 6.4.1. Research & development market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Oligonucleotide synthesis
      • 6.4.2.1. Oligonucleotide synthesis tumors market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.2.2. PCR
      • 6.4.2.2.1. PCR synthesis tumors market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.2.3. NGS
      • 6.4.2.3.1. NGS synthesis tumors market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.2.4. CRISPR
      • 6.4.2.4.1. CRISPR synthesis tumors market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.2.5. Cloning and mutagenesis
      • 6.4.2.5.1. Cloning and mutagenesis synthesis tumors market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.2.6. Others
      • 6.4.2.6.1. Others synthesis tumors market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Gene synthesis
      • 6.4.3.1. Gene synthesis market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.3.2. Synthetic biology
      • 6.4.3.2.1. Synthetic biology tumors market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.3.3. Vaccine development
      • 6.4.3.3.1. Vaccine development synthesis tumors market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.3.4. Genetic engineering
      • 6.4.3.4.1. Genetic engineering synthesis tumors market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.3.5. Others
      • 6.4.3.5.1. Others synthesis tumors market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Diagnostics
    • 6.5.1. Diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Therapeutics
    • 6.6.1. Therapeutics market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. RNAi therapies
      • 6.6.2.1. RNAi therapies market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. Antisense and oligonucleotide-based therapies
      • 6.6.3.1. Antisense and oligonucleotide-based therapies market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Others
      • 6.6.4.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. DNA Synthesis Market: End-Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global DNA Synthesis Market End-use Movement Analysis
  • 7.3. Global DNA Synthesis Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 7.4. Biopharmaceutical & Diagnostic Companies
    • 7.4.1. Biopharmaceutical & diagnostic companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. Academic & research institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Contract Research Organizations
    • 7.6.1. Contract Research Organizations market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. DNA Synthesis Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Competitive scenario
      • 8.5.7.3. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Competitive scenario
      • 8.5.8.3. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.9. Denmark
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Competitive scenario
      • 8.5.9.3. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive scenario
      • 8.6.3.3. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Competitive scenario
      • 8.6.4.3. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Competitive scenario
      • 8.6.5.3. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Competitive scenario
      • 8.6.6.3. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Competitive scenario
      • 8.6.7.3. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. Mexico
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Competitive scenario
      • 8.7.3.3. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Argentina
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Competitive scenario
      • 8.7.4.3. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Competitive scenario
      • 8.8.2.3. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Competitive scenario
      • 8.8.3.3. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. Competitive scenario
      • 8.8.4.3. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key country dynamics
      • 8.8.5.2. Competitive scenario
      • 8.8.5.3. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2023
  • 9.4. Company Profiles/Listing
    • 9.4.1. Thermo Fisher Scientific Inc.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Twist Bioscience
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. BIONEER CORPORATION
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Eton Bioscience, Inc
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. LGC Biosearch Technologies
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. IBA Lifesciences GmbH
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Eurofins Scientific
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Integrated DNA Technologies, Inc.
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Quintara Biosciences
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. GenScript
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives